Cited by 199Drug-Induced Hepatotoxicity and ProtectionAnimal testing and alternativesLiver physiology and pathology

The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.

Competency of different cell models to predict human hepatotoxic drugs

Gómez-Lechón, M José, Tolosa, Laia, Conde, Isabel, Donato, M Teresa·2014·Expert Opinion on Drug Metabolism & Toxicology

DOI 10.1517/17425255.2014.967680

Open this paper in CoChat — free account

Abstract

Introduction The liver is the most important target for drug-induced toxicity. This vulnerability results from functional liver features and its role in the metabolic elimination of most drugs. Drug-induced liver injury is a significant leading cause of acute, chronic liver disease and an important safety issue when developing new drugs. Areas covered This review describes the advantages and limitations of hepatic cell-based models for early safety risk assessment during drug development. These models include hepatocytes cultured as monolayer, collagen-sandwich; emerging complex 3D configuration; liver-derived cell lines; stem cell-derived hepatocytes. Expert opinion In vitro toxicity assays performed in hepatocytes or hepatoma cell lines can potentially provide rapid and cost-effective early feedback to identify toxic candidates for compound prioritization. However, their capacity to predict hepatotoxicity depends critically on cells' functional performance. In an attempt to improve and prolong functional properties of cultured cells, different strategies to recreate the in vivo hepatocyte environment have been explored. 3D cultures, co-cultures of hepatocytes with other cell types and microfluidic devices seem highly promising for toxicological studies. Moreover, hepatocytes derived from human pluripotent stem cells are emerging cell-based systems that may provide a stable source of hepatocytes to reliably screen metabolism and toxicity of candidate compounds.

Integrity signals

Registry

Crossref · 10.1517/17425255.2014.967680

Cites

129 of 129 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells
Si-Tayeb, K., Noto, F. K., Nagaoka, M., Li, J., Battle, M. A., Duris, C., North, P. E., Dalton, S., & Duncan, S. A. (2010) · Hepatology · doi:10.1002/hep.23354 · Cited by 1,282
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Self-citation
Recent advances in three‐dimensional multicellular spheroid culture for biomedical research
Lin, R., & Chang, H. (2008) · Biotechnology Journal · doi:10.1002/biot.200700228 · Cited by 1,264
Microscale culture of human liver cells for drug development
Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219
Bile salt transporters: molecular characterization, function, and regulation
Trauner, M., & Boyer, J. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00027.2002 · Cited by 999
Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland
Björnsson, E. S., Bergmann, O. M., Björnsson, H. K., Kvaran, R. B., & Olafsson, S. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.006 · Cited by 865
Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772
Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies
Hewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735
Self-citation
EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS
Aninat, C., Piton, A., Glaise, D., Charpentier, T. L., Langouët, S., Morel, F., Guguen‐Guillouzo, C., & Guillouzo, A. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006759 · Cited by 708
High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening
O’Brien, P. J., Irwin, W., Diaz, D., Howard-Cofield, E., Krejsa, C. M., Slaughter, M. R., Gao, B., Kaludercic, N., Angeline, A., Bernardi, P., et al. (2006) · Archives of Toxicology · doi:10.1007/s00204-006-0091-3 · Cited by 609

Show all 129 references

Research works printed but not linked: 4

Ohkura T, 2014, Drug Metab Pharmacokinet
Ramaiahgari SC, 2014, Arch Toxicol, 88, 1083
Klein S, 2013, J Appl Toxicol
Katsuda T, 2012, J Stem Cells, 7, 1

Sorted by citations

Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease
Bell, C. C., Hendriks, D. F. G., Moro, S. M. L., Ellis, E., Walsh, J., Renblom, A., Fredriksson Puigvert, L., Dankers, A. C. A., Jacobs, F., Snoeys, J., et al. (2016) · Scientific Reports · doi:10.1038/srep25187 · Cited by 739
Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study
Bell, C. C., Dankers, A. C. A., Lauschke, V. M., Sison-Young, R., Jenkins, R., Rowe, C., Goldring, C. E., Park, K., Regan, S. L., Walker, T., et al. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfx289 · Cited by 327
Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates
Lauschke, V. M., Hendriks, D. F. G., Bell, C. C., Andersson, T. B., & Ingelman-Sundberg, M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00150 · Cited by 241
Long-term functional maintenance of primary human hepatocytes in vitro
Xiang, C., Du, Y., Meng, G., Soon Yi, L., Sun, S., Song, N., Zhang, X., Xiao, Y., Wang, J., Yi, Z., et al. (2019) · Science · doi:10.1126/science.aau7307 · Cited by 223
Toxicology Strategies for Drug Discovery: Present and Future
Blomme, E. A. G., & Will, Y. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00407 · Cited by 201
Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell–Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury
Bell, C. C., Lauschke, V. M., Vorrink, S. U., Palmgren, H., Duffin, R., Andersson, T. B., & Ingelman-Sundberg, M. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074369 · Cited by 201
Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined Conditions
Vorrink, S. U., Zhou, Y., Ingelman-Sundberg, M., & Lauschke, V. M. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy058 · Cited by 187
Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics
Vorrink, S. U., Ullah, S., Schmidt, S., Nandania, J., Velagapudi, V., Beck, O., Ingelman‐Sundberg, M., & Lauschke, V. M. (2017) · The FASEB Journal · doi:10.1096/fj.201601375r · Cited by 172
Naturally-Derived Biomaterials for Tissue Engineering Applications
Brovold, M., Almeida, J. I., Plá-Palacín, I., Sainz‐Arnal, P., Sánchez‐Romero, N., Rivas, J. J., Almeida, H., Dachary, P. R., Serrano, T., Söker, S., et al. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0947-2_23 · Cited by 168
Characterization of a functional C3A liver spheroid model
Gaskell, H., Sharma, P., Colley, H. E., Murdoch, C., Williams, D. P., & Webb, S. D. (2016) · Toxicology Research · doi:10.1039/c6tx00101g · Cited by 131
Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery
Ewart, L. C., Dehne, E., Fabre, K. M., Gibbs, S., Hickman, J. J., Hornberg, E., Ingelman‐Sundberg, M., Jang, K., Jones, D. R., Lauschke, V. M., et al. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052722 · Cited by 136
Amino acid levels determine metabolism and CYP450 function of hepatocytes and hepatoma cell lines
Boon, R., Kumar, M., Tricot, T., Elia, I., Ordovás, L., Jacobs, F., One, J., Smedt, J. D., Eelen, G., Bird, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15058-6 · Cited by 122
Human Organoids for Predictive Toxicology Research and Drug Development
Matsui, T., & Shinozawa, T. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.767621 · Cited by 109
Liver organ-on-chip models for toxicity studies and risk assessment
Messelmani, T., Morisseau, L., Sakai, Y., Legallais, C., Goff, A. L., Leclerc, É., & Jellali, R. (2022) · Lab on a Chip · doi:10.1039/d2lc00307d · Cited by 113
Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine
Chen, X., Zhang, Y. S., Zhang, X., & Liu, C. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.09.022 · Cited by 112
The potential of induced pluripotent stem cell derived hepatocytes
Hannoun, Z., Steichen, C., Dianat, N., Weber, A., & Dubart‐Kupperschmitt, A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.025 · Cited by 107
Fast, robust and effective decellularization of whole human livers using mild detergents and pressure controlled perfusion
Willemse, J., Verstegen, M. M. A., Vermeulen, A., Schurink, I. J., Roest, H. P., van der Laan, L. J. W., & de Jonge, J. (2020) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.110200 · Cited by 102
The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity
Lauschke, V. M., & Ingelman‐Sundberg, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101714 · Cited by 92
Assessing Toxicity with Human Cell-Based In Vitro Methods
Zink, D., Chuah, J. K. C., & Ying, J. Y. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.008 · Cited by 87
Metabolic activation and drug‐induced liver injury: in vitro approaches for the safety risk assessment of new drugs
Gómez‐Lechón, M. J., Tolosa, L., & Donato, M. T. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3277 · Cited by 87
Self-citation
Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury
Zhou, Y., Shen, J. X., & Lauschke, V. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01093 · Cited by 85
Liver three-dimensional cellular models for high-throughput chemical testing
Yang, S., Ooka, M., Margolis, R. J., & Xia, M. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100432 · Cited by 75
Experimental liver models: From cell culture techniques to microfluidic organs‐on‐chip
Polidoro, M. A., Ferrari, E., Marzorati, S., Lleò, A., & Rasponi, M. (2021) · Liver International · doi:10.1111/liv.14942 · Cited by 77
Three-Dimensional Spheroids With Primary Human Liver Cells and Differential Roles of Kupffer Cells in Drug-Induced Liver Injury
Li, F., Cao, L., Parikh, S., & Zuo, R. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.02.021 · Cited by 72
Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing
Tolosa, L., Gómez-Lechón, M. J., López, S. A., Guzmán, C., Castell, J. V., Donato, M. T., & Jover, R. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw078 · Cited by 69
Self-citation
Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
Segovia-Zafra, A., Di Zeo-Sánchez, D. E., López-Gómez, C., Pérez-Valdés, Z., García-Fuentes, E., Andrade, R. J., Lucena, M. I., & Villanueva-Paz, M. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.013 · Cited by 70
Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk
Raschi, E. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i13.1761 · Cited by 68
Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer
Fong, E. L. S., Toh, T. B., Lin, Q. X. X., Liu, Z., Hooi, L., Rashid, M. B. M. A., Benoukraf, T., Chow, E. K., Huynh, T. H., & Yu, H. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.12.026 · Cited by 67
Impact of cell types and culture methods on the functionality of in vitro liver systems – A review of cell systems for hepatotoxicity assessment
Kyffin, J. A., Sharma, P., Leedale, J., Colley, H. E., Murdoch, C., Mistry, P., & Webb, S. D. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.01.023 · Cited by 64
Critical differences in drug metabolic properties of human hepatic cellular models, including primary human hepatocytes, stem cell derived hepatocytes, and hepatoma cell lines
Kvist, A. J., Kanebratt, K. P., Walentinsson, A., Palmgren, H., O’Hara, M., Björkbom, A., Andersson, L. C., Ahlqvist, M. M., & Andersson, T. B. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.06.026 · Cited by 61
3D Cultivation Techniques for Primary Human Hepatocytes
Bachmann, A., Moll, M., Gottwald, E., Nies, C., Zantl, R., Wagner, H., Burkhardt, B., Sánchez, J., Ladurner, R., Thasler, W., et al. (2015) · Microarrays · doi:10.3390/microarrays4010064 · Cited by 59
Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening
Gómez-Lechón, M. J., & Tolosa, L. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1756-1 · Cited by 57
Self-citation
Current Perspective: 3D Spheroid Models Utilizing Human-Based Cells for Investigating Metabolism-Dependent Drug-Induced Liver Injury
Cox, C. R., Lynch, S., Goldring, C. E., & Sharma, P. (2020) · Frontiers in Medical Technology · doi:10.3389/fmedt.2020.611913 · Cited by 58
Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development—Current State-of-the-Art and Future Perspectives
Youhanna, S. C., Kemas, A. M., Preiss, L. C., Zhou, Y., Shen, J. X., Cakal, S. D., Paqualini, F. S., Goparaju, S. K., Shafagh, R. Z., Lind, J. U., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000238 · Cited by 61
Liver-on-a-chip devices: the pros and cons of complexity
Dalsbecker, P., Adiels, C. B., & Goksör, M. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00346.2021 · Cited by 56
In Vitro Models for Studying Chronic Drug-Induced Liver Injury
Donato, M. T., Ferrer, G. G., & Tolosa, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911428 · Cited by 52
Self-citation
Acetaminophen cytotoxicity is ameliorated in a human liver organotypic co-culture model
Nelson, L. J., Navarro, M., Treskes, P., Samuel, K., Tura-Ceide, O., Morley, S. D., Hayes, P. C., & Plevris, J. N. (2015) · Scientific Reports · doi:10.1038/srep17455 · Cited by 51
Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling
Shao, W., Xu, H., Zeng, K., Ye, M., Pei, R., & Wang, K. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04139-2 · Cited by 55
Bioprinting of Human Liver‐Derived Epithelial Organoids for Toxicity Studies
Bouwmeester, M., Bernal, P. N., Oosterhoff, L. A., van Wolferen, M. E., Lehmann, V., Vermaas, M., Buchholz, M., Peiffer, Q. C., Malda, J., van der Laan, L. J. W., et al. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202100327 · Cited by 51
Three-dimensional in vitro gut model on a villi-shaped collagen scaffold
Yi, B., Shim, K. Y., Ha, S. K., Han, J., Hoang, H.-H., Choi, I., Park, S., & Sung, J. H. (2017) · BioChip Journal · doi:10.1007/s13206-017-1307-8 · Cited by 47
Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury
Tolosa, L., Jiménez, N., Pérez, G., Castell, J. V., Gómez-Lechón, M. J., & Donato, M. T. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2036-4 · Cited by 44
Self-citation
Development of a cost-effective automated platform to produce human liver spheroids for basic and applied research
Lucendo‐Villarin, B., Meseguer-Ripolles, J., Drew, J., Fischer, L., Ma, E., Flint, O. P., Simpson, K. J., Machesky, L. M., Mountford, J. C., & Hay, D. C. (2020) · Biofabrication · doi:10.1088/1758-5090/abbdb2 · Cited by 43
Characterisation of a functional rat hepatocyte spheroid model
Kyffin, J. A., Sharma, P., Leedale, J., Colley, H. E., Murdoch, C., Harding, A. L., Mistry, P., & Webb, S. D. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.12.014 · Cited by 43
Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening
Wang, Z., Li, W., Jing, H., Ding, M., Fu, G., Yuan, T., Huang, W., Dai, M., Tang, D., Zeng, M., et al. (2019) · Theranostics · doi:10.7150/thno.34520 · Cited by 43
Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery
Fu, J., Qiu, H., & Tan, C. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041300 · Cited by 42
The role of epigenetic modifiers in extended cultures of functional hepatocyte-like cells derived from human neonatal mesenchymal stem cells
Cipriano, M., Correia, J. C., Camões, S. P., Oliveira, N., Cruz, P. E., Cruz, H., Castro, M., Ruas, J. L., Santos, J. M., & Miranda, J. P. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1901-x · Cited by 44
Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury
Weaver, R. J., Betts, C. J., Blomme, E. A. G., Gerets, H. H. J., Jensen, K. G., Hewitt, P. G., Juhila, S., Labbe, G., Liguori, M. J., Mesens, N., et al. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1341489 · Cited by 41
3D-bioprinted HepaRG cultures as a model for testing long term aflatoxin B1 toxicity in vitro
Schmidt, K., Berg, J., Röhrs, V., Kurreck, J., & Al‐Zeer, M. A. (2020) · Toxicology Reports · doi:10.1016/j.toxrep.2020.11.003 · Cited by 42
Advancements in stem cell-derived hepatocyte-like cell models for hepatotoxicity testing
Jin, M., Xiao, Y., Liao, W., Chen, Q., Yang, W., Li, Y., Li, S., Gao, Y., Peng, Q., & Zhou, S. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02152-9 · Cited by 41
In vitro prediction of organ toxicity: the challenges of scaling and secondary mechanisms of toxicity
Hengstler, J. G., Sjogren, A.-K. M., Zink, D., & Hornberg, J. J. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02669-7 · Cited by 41
Multiparametric assay using HepaRG cells for predicting drug-induced liver injury
貴文, 富., Okamura, H., Satsukawa, M., Yokoi, T., & Konno, Y. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.04.014 · Cited by 38
High-Content Screening for the Detection of Drug-Induced Oxidative Stress in Liver Cells
Donato, M. T., & Tolosa, L. (2021) · Antioxidants · doi:10.3390/antiox10010106 · Cited by 41
Self-citation
The hepatotoxicity assessment of micro/nanoplastics: A preliminary study to apply the adverse outcome pathways
Ge, Y., Yang, S., Zhang, T., Wan, X., Zhu, Y., Yang, F., Yin, L., Pu, Y., & Liang, G. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.165659 · Cited by 43
Stem-cell derived hepatocyte-like cells for the assessment of drug-induced liver injury
Donato, M. T., & Tolosa, L. (2019) · Differentiation · doi:10.1016/j.diff.2019.02.004 · Cited by 38
Self-citation
Simultaneously discovering the fate and biochemical effects of pharmaceuticals through untargeted metabolomics
Bowen, T. J., Southam, A. D., Hall, A. R., Weber, R. J. M., Lloyd, G. R., Macdonald, R., Wilson, A., Pointon, A., & Viant, M. R. (2023) · Nature Communications · doi:10.1038/s41467-023-40333-7 · Cited by 36
Long-term and mechanistic evaluation of drug-induced liver injury in Upcyte human hepatocytes
Tolosa, L., Jiménez, N., Pelechá-Salvador, M., Castell, J. V., Gómez-Lechón, M. J., & Donato, M. T. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2349-y · Cited by 35
Self-citation
Upcyte Human Hepatocytes: a Potent In Vitro Tool for the Prediction of Hepatic Clearance of Metabolically Stable Compounds
Schaefer, M., Schänzle, G., Bischoff, D., & Süßmuth, R. D. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.067348 · Cited by 34
HepG2 (C3A) spheroids show higher sensitivity compared to HepaRG spheroids for drug-induced liver injury (DILI)
Basharat, A., Rollison, H. E., Williams, D. P., & Ivanov, D. P. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115279 · Cited by 37
Primary‐like human hepatocytes genetically engineered to obtain proliferation competence display hepatic differentiation characteristics in monolayer and organotypical spheroid cultures
Herzog, N., Hansen, M., Miethbauer, S., Schmidtke, K., Anderer, U., Lupp, A., Sperling, S., Seehofer, D., Damm, G., Scheibner, K., et al. (2015) · Cell Biology International · doi:10.1002/cbin.10574 · Cited by 33
Organs-on-chips and Its Applications
Sun, W., Chen, Y., Luo, G., Zhang, M., Zhang, H., Wang, Y., & Hu, P. (2016) · Chinese Journal of Analytical Chemistry · doi:10.1016/s1872-2040(16)60920-9 · Cited by 35
Human Three-Dimensional Hepatic Models: Cell Type Variety and Corresponding Applications
Xu, Q. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.730008 · Cited by 37
Chlorpyrifos induces cytotoxicity via oxidative stress and mitochondrial dysfunction in HepG2 cells
Montanarí, C., Franco-Campos, F., Taroncher, M., Rodríguez-Carrasco, Y., Zingales, V., & Ruiz, M.-J. (2024) · Food and Chemical Toxicology · doi:10.1016/j.fct.2024.114933 · Cited by 32
Hydrogel-Based Strategies for Liver Tissue Engineering
Zhang, Y., Li, L., Dong, L., Cheng, Y., Huang, X., Xue, B., Jiang, C., Cao, Y., & Yang, J. (2024) · Chem & Bio Engineering · doi:10.1021/cbe.4c00079 · Cited by 33
Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver’s Extracellular Matrix
Messelmani, T., Goff, A. L., Souguir, Z., Maes, V., Roudaut, M., Vandenhaute, E., Maubon, N., Legallais, C., Leclerc, É., & Jellali, R. (2022) · Bioengineering · doi:10.3390/bioengineering9090443 · Cited by 31
Acetaminophen toxicity in rat and mouse hepatocytesin vitro
Kučera, O., Endlicher, R., Rychtrmoc, D., Lotková, H., Sobotka, O., & Červinková, Z. (2016) · Drug and Chemical Toxicology · doi:10.1080/01480545.2016.1255953 · Cited by 29
Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques
Guo, K., & van den Beucken, T. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01317-2 · Cited by 28
Spatiotemporal pharmacometabolomics based on ambient mass spectrometry imaging to evaluate the metabolism and hepatotoxicity of amiodarone in HepG2 spheroids
Li, L., Zang, Q., Li, X., Zhu, Y., Wen, S., He, J., Zhang, R., & Abliz, Z. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.04.007 · Cited by 28
Three-dimensional hepatocyte culture system for the study of Echinococcus multilocularis larval development
Li, L., Chen, B., Yan, H., Zhao, Y., Lou, Z., Li, J., Fu, B., Zhu, X., McManus, D. P., Dai, J., et al. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006309 · Cited by 27
Conditions for maintenance of hepatocyte differentiation and function in 3D cultures
Handin, N., Mickols, E., Ölander, M., Rudfeldt, J., Blom, K., Nyberg, F., Senkowski, W., Urdzik, J., Maturi, V., Fryknäs, M., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103235 · Cited by 29
Use of human derived liver cells for the detection of genotoxins in comet assays
Mišík, M., Nersesyan, A. K., Ropek, N., Huber, W. W., Haslinger, E., & Knasmüller, S. (2018) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2018.12.003 · Cited by 27
Sphingolipid metabolism as a marker of hepatotoxicity in drug-induced liver injury
Li, L., Wang, H., & Jones, J. W. (2020) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2020.106484 · Cited by 25
Upgrading HepG2 cells with adenoviral vectors that encode drug-metabolizing enzymes: application for drug hepatotoxicity testing
Gómez-Lechón, M. J., Tolosa, L., & Donato, M. T. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1238459 · Cited by 26
Self-citation
A DMSO-free hepatocyte maturation medium accelerates hepatic differentiation of HepaRG cells in vitro
Wang, Z., Li, W., Li, Q., Jing, H., Yuan, T., Fu, G., Tang, D., Zhang, H., Yan, H., & Zhai, B. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109010 · Cited by 23
An effective protocol for pharmacological defatting of primary human hepatocytes which is non-toxic to cholangiocytes or intrahepatic endothelial cells
BOTEON, Y. L., Wallace, L. M., Boteon, A. P. C. D. S., Mirza, D. F., Mergental, H., Bhogal, R. H., & Afford, S. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201419 · Cited by 23
Which concentrations are optimal for in vitro testing?
Albrecht, W. (2020) · EXCLI journal · doi:10.17179/excli2020-2761 · Cited by 22
Cynomolgus macaques naturally infected with Trypanosoma cruzi-I exhibit an overall mixed pro-inflammatory/modulated cytokine signature characteristic of human Chagas disease
Vitelli-Avelar, D. M., Sathler-Avelar, R., Mattoso-Barbosa, A. M., Gouin, N., Perdigão-de-Oliveira, M., Valério-dos-Reis, L., Costa, R. P., Elói-Santos, S. M., Gomes, M. D. S., do Amaral, L. R., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005233 · Cited by 22
Assessment of food toxicology
Gosslau, A. (2016) · Food Science and Human Wellness · doi:10.1016/j.fshw.2016.05.003 · Cited by 23
In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation
Mirahmad, M., Sabourian, R., Mahdavi, M. R., Larijani, B. A., & Safavi, M. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2064487 · Cited by 21
A pumpless liver-on-a-chip for drug hepatotoxicity analysis
Jiao, D., Xie, L., & Xing, W. (2024) · The Analyst · doi:10.1039/d4an00602j · Cited by 21
Recent advances in the development of in vitro liver models for hepatotoxicity testing
Lu, S., Zhang, J., Lin, S., Zheng, D., Shen, Y., Qin, J., Li, Y. Y., & Wang, S. (2021) · Bio-Design and Manufacturing · doi:10.1007/s42242-021-00142-7 · Cited by 21
Cytotoxic effects of individual and combined sterigmatocystin and nivalenol on liver hepatocellular carcinoma cells
Zingales, V., Fedeli, C., Fernández-Franzón, M., & Ruiz, M.-J. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111473 · Cited by 20
Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies
Donato, M. T., Gómez-Lechón, M. J., & Tolosa, L. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1271784 · Cited by 20
Self-citation
Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and Safety
Meseguer-Ripolles, J., Khetani, S. R., Blanco, J. G., Iredale, M., & Hay, D. C. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0171-8 · Cited by 19
3D Bioprinted Liver-on-a-Chip for Drug Cytotoxicity Screening
Huh, J., Parra, J. P. R. L. L., Copus, J. S., Kang, H., Bishop, C. E., Söker, S., Murphy, S. V., Shupe, T. D., Yoo, J. J., Lee, S. J., et al. (2023) · Tissue Engineering Part A · doi:10.1089/ten.tea.2023.0212 · Cited by 19
A shift in paradigm towards human biology‐based systems for cholestatic‐liver diseases
Noor, F. (2015) · The Journal of Physiology · doi:10.1113/jp271124 · Cited by 19
Expression of miRNA-122 Induced by Liver Toxicants in Zebrafish
Nam, H.-S., Hwang, K., Jeong, Y.-M., Ryu, J.-I., Choi, T. Y., Bae, M., Son, W., You, K., Son, H., & Kim, C. (2016) · BioMed Research International · doi:10.1155/2016/1473578 · Cited by 19
Tethered primary hepatocyte spheroids on polystyrene multi-well plates for high-throughput drug safety testing
Tasnim, F., Singh, N. H., Tan, E. K. F., Xing, J., Li, H., Hissette, S., Manesh, S., Fulwood, J., Gupta, K., Ng, C. W., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61699-4 · Cited by 19
Microengineered systems with iPSC-derived cardiac and hepatic cells to evaluate drug adverse effects
Dame, K., & Ribeiro, A. J. S. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220959598 · Cited by 19
Influence of liver extracellular matrix in predicting drug-induced liver injury: an alternate paradigm
Sasikumar, S., Chameettachal, S., Kingshott, P., Cromer, B., & Pati, F. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00994 · Cited by 18
Predicting direct hepatocyte toxicity in humans by combining high-throughput imaging of HepaRG cells and machine learning-based phenotypic profiling
Hussain, F., Basu, S., Heng, J. J. H., Loo, L., & Zink, D. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02778-3 · Cited by 21
Emerging Three-Dimensional Hepatic Models in Relation to Traditional Two-Dimensional In Vitro Assays for Evaluating Drug Metabolism and Hepatoxicity
Milner, E., Ainsworth, M., McDonough, M., Stevens, B. D., Buehrer, J., Delzell, R., Wilson, C., & Barnhill, J. C. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100060 · Cited by 19
Advancing hepatotoxicity assessment: current advances and future directions
Kim, Y., Kim, Y., & Kim, Y. (2025) · Toxicological Research · doi:10.1007/s43188-025-00289-w · Cited by 22
A new cell-sized support for 3D cell cultures based on recombinant spider silk fibers
Stern-Tal, D., Ittah, S., & Sklan, E. (2021) · Journal of Biomaterials Applications · doi:10.1177/08853282211037781 · Cited by 19
Role of toxicokinetics and alternative testing strategies in pyrrolizidine alkaloid toxicity and risk assessment; state-of-the-art and future perspectives
Ning, J., Chen, L., & Rietjens, I. M. C. M. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110572 · Cited by 16
Liver regeneration biology: Implications for liver tumour therapies
Hadjittofi, C., Feretis, M., Martin, J. L., Harper, S., & Huguet, E. (2021) · World Journal of Clinical Oncology · doi:10.5306/wjco.v12.i12.1101 · Cited by 18
Mapping Interindividual Variability of Toxicodynamics Using High-Throughput Transcriptomics and Primary Human Hepatocytes from Fifty Donors
Niemeijer, M., Więcek, W., Fu, S., Huppelschoten, S., Bouwman, P., Baze, A., Parmentier, C., Richert, L., Paules, R. S., Bois, F. Y., et al. (2024) · Environmental Health Perspectives · doi:10.1289/ehp11891 · Cited by 16
Application of triple co-cultured cell spheroid model for exploring hepatotoxicity and metabolic pathway of AFB1
Ma, X., Sun, J., Ye, Y., Ji, J., & Sun, X. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.150840 · Cited by 15
Single-cell metabolic profiling of primary human hepatocytes shows heterogenous responses to drug metabolism
Sanchez-Quant, E., Richter, M., Martinez‐Jimenez, C. P., & Colomé‐Tatché, M. (2022) · Genome biology · doi:10.1016/s0168-8278(22)01138-2 · Cited by 18
Characterization of a long-term mouse primary liver 3D tissue model recapitulating innate-immune responses and drug-induced liver toxicity
Nudischer, R., Renggli, K., Hierlemann, A. R., Roth, A. B., & Bertinetti‐Lapatki, C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235745 · Cited by 15
Metabolomic profiling during the differentiation of human induced pluripotent stem cells into hepatocyte-like cells
Jellali, R., Lereau, M., Tauran, Y., Gilard, F., Danoy, M., Kido, T., Miyajima, A., Sakai, Y., & Leclerc, É. (2019) · Differentiation · doi:10.1016/j.diff.2019.10.006 · Cited by 14

Authors: Gómez-Lechón, M. J., Tolosa, L., Conde, I., & Donato, M. T.
Affiliations: Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
Instituto de Investigación Sanitaria La Fe (ES)
Universitat de València (ES)
ORCID: Tolosa, Laia
Conde, Isabel
Donato, M Teresa
Venue: Expert Opinion on Drug Metabolism & Toxicology
Publisher: Informa UK Limited
Published: 2014-10-09
Volume: 10
Issue: 11
Pages: 1553-1568
ISSN: 1742-5255 (ISSN-L)
1744-7607
DOI: 10.1517/17425255.2014.967680
OpenAlex: W2035459829
Cited by: 199
References: 129
Citations by year: 2026: 5 · 2025: 17 · 2024: 19 · 2023: 17 · 2022: 16 · 2021: 23 · 2020: 25 · 2019: 16 · 2018: 16 · 2017: 14 · 2016: 18 · 2015: 12 · 2014: 1
FWCI: 2.68
Type: journal article
Language: en
Open access: closed
Locations: Expert Opinion on Drug Metabolism & Toxicology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: hepatotoxicity, drug-induced liver injury, hepatocyte models, hepatocyte monolayer culture, hepatoma cell lines, stem cell-derived hepatocytes, pluripotent stem cells, co-culture, microfluidics, in vitro toxicity prediction, hepatocyte function
MeSH terms: Animals, Cell Line, Cells, Cultured, Humans, Liver, Toxicity Tests, Hepatocytes, Cell Line, Tumor, Chemical and Drug Induced Liver Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Competency of different cell models to predict human hepatotoxic drugs

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks